18F FDG PET/CT and Head and Neck Cancer Patient Management and Outcomes

被引：23

作者：

Sheikhbahaei, Sara ^{[1
]}

Marcus, Charles ^{[2
]}

Subramaniam, Rathan M. ^{[3
]}

机构：

[1] Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA

[2] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[3] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA

来源：

PET CLINICS | 2015年 / 10卷 / 02期

关键词：

Head and neck squamous cell cancer; Survival outcome; Management change; Prognosis; Therapy response;

D O I：

10.1016/j.cpet.2014.12.001

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

There is a growing body of evidence that point to the value of 18F fluoro-deoxyglucose-PET/CT in the management of head and neck cancer (HNC) patients and predicting patient-related outcomes. FDG-PET/CT changes the baseline staging (compared with CT or MR imaging), guides appropriate therapy selection, separates the responders and non-responders for therapy assessment, adds value to clinical assessment in follow-up, and predicts patient survival outcomes. FDG-PET/CT can identify the recurrences in earlier stages and individualize follow-up regimens in HNC patients. This article reviews the value of FDG-PET/CT in management strategy and survival outcome of HNC patients. © 2015 Elsevier Inc. All rights reserved.

引用

页码：125 / 145

页数：21

共 50 条

[1] Role of [18F]-FDG PET-CT in the management of the head and neck cancers
Fakhry, Nicolas
Barberet, Marie
Lussato, David
Cammilleri, Serge
Mundler, Olivier
Giovanni, Antoine
Zanaret, Michel
[J]. BULLETIN DU CANCER, 2006, 93 (10) : 1017 - 1025
[2] 18F-FDG PET/CT in head and neck cancer
Kresnik, E
Gallowitsch, HJ
Igerc, I
Gomez, I
Reinprecht, P
Hausegger, K
Lind, P
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S325 - S325
[3] Improved Value of [18F]-FDG PET/CT for Lymph Node Metastasis in Head and Neck Cancer
Betech-Antar, V.
Minguez, F.
Bronte, A.
Bastidas, J. F.
Rosales, J. J.
Serrano, Z.
Pareja, F.
Garcia-Velloso, M. J.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S457 - S458
[4] Impact of F-18 FDG PET/CT on management in head and neck cancer patients
Tam, H. H.
Patel, N.
Sandhu, R.
Win, Z.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S250 - S250
[5] The Role of [18F]-FDG-PET/CT and PET/MRI in the Management of Head and Neck Squamous Cell Carcinoma
Bural, Gonca
Torigian, Drew
Learned, Kim
Houseni, Mohamed
[J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
[6] The role of [18F]FDG PET/CT for gastric cancer management
Salmanoglu, Ebru
[J]. NUCLEAR MEDICINE REVIEW, 2021, 24 (02) : 99 - 103
[7] [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer
Vrachimis, Alexis
Burg, Matthias Christian
Wenning, Christian
Allkemper, Thomas
Weckesser, Matthias
Schaefers, Michael
Stegger, Lars
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (02) : 212 - 220
[8] [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer
Alexis Vrachimis
Matthias Christian Burg
Christian Wenning
Thomas Allkemper
Matthias Weckesser
Michael Schäfers
Lars Stegger
[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 212 - 220
[9] F-18 FDG PET/CT following dental extraction in a patient with head and neck cancer
Bybel, Bohdan
[J]. CLINICAL NUCLEAR MEDICINE, 2007, 32 (09) : 741 - 742
[10] Prognostic value of haematological parameters and [18F]FDG PET/CT metabolic parameters in head and neck cancer
Garcia, A. Baena
de la Torre, J. R. Infante
Carbonero, R. Barco
Esteve, A. Martinez
Barragan, V. Vera
Vicente, J. Serrano
Granero, P. Jimenez
Costero, A. Utrera
[J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2024, 43 (01): : 31 - 38

← 1 2 3 4 5 →